الرئيسية
الأبحاث العلمية
التدريس
التدرج الوظيفى
السيرة الذاتية
البحث الأكاديمى
إتصل بنا
الموقع الجديد
المجالات البحثية
Bacteriology
Immunology
Microbiology
Molecular Biology
Molecular Immunology
Virology
الابحاث العلمية
1 -
Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR Acinetobacter baumannii (2025).
2 -
Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa (2025).
3 -
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence (2025).
4 -
Bacteriophage resurrection: Innovative impacts in medicine, biotechnology, and environmental solutions (2024).
5 -
Bacteriophage resurrection: Innovative impacts in medicine, biotechnology, and environmental solutions (2024).
6 -
Characterization and Comparative Genomic Analysis of vB_BceM_CEP1: A Novel Temperate Bacteriophage Infecting Burkholderia cepacia Complex (2024).
7 -
Analytical Methodologies for the Estimation of Oxazolidinone Antibiotics as Key Members of anti-MRSA Arsenal: A Decade in Review (2024).
8 -
6-Paradol exhibits antimicrobial, anti-quorum sensing and anti-virulence capacities on gram-negative bacteria: In vitro and in vivo studies (2024).
9 -
6-Paradol exhibits antimicrobial, anti-quorum sensing and anti-virulence capacities on gram-negative bacteria: In vitro and in vivo studies (2024).
10 -
Characterization and Comparative Genomic Analysis of vB_BceM_CEP1: A Novel Temperate Bacteriophage Infecting Burkholderia cepacia Complex (2024).
11 -
A review on recent analytical methodologies developed for the micro-determination of piperacillin in different matrices (2024).
12 -
Arctigenin from Burdock Root Exhibits Potent Antibacterial and Anti-Virulence Properties against Pseudomonas aeruginosa (2024).
13 -
Honokiol from Magnolia Tree Exhibits Antibacterial and Anti-virulence Potential against Pseudomonas aeruginosa (2024).
14 -
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing (2024).
15 -
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing (2024).
16 -
A Retrospective Exploration of Pre-operative Antibiotic Prophylaxis with Cefazolin in Cesarean Sections: Implications for Obstetrics and Gynecologic Surgery (2024).
17 -
What’s old is new again: Insights into diabetic foot microbiome (2024).
18 -
Investigating Sulforaphane’s anti-virulence and anti-quorum sensing properties against Pseudomonas aeruginosa (2024).
19 -
Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogens (2024).
20 -
Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches (2024).
21 -
Antimicrobial and anti-virulence activities of 4-shogaol from grains of paradise against gram-negative bacteria: Integration of experimental and computational methods (2024).
22 -
Thymoquinone is a natural antibiofilm and pathogenicity attenuating agent in Pseudomonas aeruginosa (2024).
23 -
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae (2024).
24 -
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae (2024).
25 -
Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa (2024).
26 -
Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa (2024).
27 -
The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model (2024).
28 -
Antimicrobial and anti-virulence activities of 4-shogaol from grains of paradise against gram-negative bacteria: Integration of experimental and computational methods (2024).
29 -
The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens (2023).
30 -
Urinary Tract Infections - New Insights (2023).
31 -
Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against Pseudomonas aeruginosa and Serratia marcescens: Insights from Molecular and In Vivo Investigations (2023).
32 -
Analytical Methodologies for the Estimation of Oxazolidinone Antibiotics as Key Members of anti-MRSA Arsenal: A Decade in Review (2023).
33 -
Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems (2023).
34 -
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death (2023).
35 -
Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria (2023).
36 -
Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria (2023).
37 -
Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate (2023).
38 -
Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins (2023).
39 -
Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins (2023).
40 -
Biofilm Lifestyle in Recurrent Urinary Tract Infections (2023).
41 -
Biofilm Lifestyle in Recurrent Urinary Tract Infections (2023).
42 -
Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4–d] pyrimidines: Synthesis, antitumor evaluation and molecular modeling study (2022).
43 -
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis (2022).
44 -
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis (2022).
45 -
Design, synthesis and antitumor evaluation of novel pyrazolo[3,4-d]pyrimidines incorporating different amino acid conjugates as potential DHFR inhibitors (2022).
46 -
Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica (2022).
47 -
Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica (2022).
48 -
Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens (2022).
49 -
Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens (2022).
50 -
Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities (2022).
51 -
Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities (2022).
52 -
Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens (2022).
53 -
Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens (2022).
54 -
Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity (2022).
55 -
Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa (2022).
56 -
Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus (2022).
57 -
Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa (2022).
58 -
Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus (2022).
59 -
Terazosin Interferes with Quorum Sensing and Type Three Secretion System and Diminishes the Bacterial Espionage to Mitigate the Salmonella Typhimurium Pathogenesis (2022).
60 -
Clonal Diversity and Epidemiological Characteristics of ST239-MRSA Strains (2022).
61 -
Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against Salmonella typhimurium Infection (2022).
62 -
Repurposing α-Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria (2022).
63 -
Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides (2022).
64 -
Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents (2022).
65 -
Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients (2022).
66 -
Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (2021).
67 -
Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (2021).
68 -
Anti-diabetics and antimicrobials: Harmony of mutual interplay (2021).
69 -
A novel use of allopurinol as a quorum sensing inhibitor in Pseudomonas aeruginosa (2021).
70 -
Not Only Antimicrobial: Metronidazole Mitigates the Virulence of Proteus mirabilis Isolated from Macerated Diabetic Foot Ulcer (2021).
71 -
Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon (2021).
72 -
Efficacy of SPG-ODN 1826 Nanovehicles in Inducing M1 Phenotype through TLR-9 Activation in Murine Alveolar J774A.1 Cells: Plausible Nano-Immunotherapy for Lung Carcinoma (2021).
73 -
Retrospective Study of Bone-TB in Oman: 2002–2019 (2021).
74 -
Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens (2021).
75 -
Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity (2021).
76 -
Repurposing of antidiabetics as Serratia marcescens virulence inhibitors (2021).
77 -
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis (2021).
78 -
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis (2021).
79 -
Thymol Nanoemulsion: A New Therapeutic Option for Extensively Drug Resistant Foodborne Pathogens (2020).
80 -
Promising Antibiofilm Agents: Recent Breakthrough against Biofilm Producing Methicillin-Resistant Staphylococcus aureus (2020).
81 -
Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa (2020).
82 -
Repurposing anti-diabetic drug “Sitagliptin” as a novel virulence attenuating agent in Serratia marcescens (2020).
83 -
Ciprofloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression (2020).
84 -
Ciproloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression (2020).
85 -
Investigating the influence of iron on Campylobacter jejuni transcriptome in response to acid stress (2020).
86 -
Prevalence of multi-drug resistant Staphylococci isolated from surgical site infections (2018).
87 -
Targeting the virulence factors of Serratia marcescens by ambroxol (2017).
88 -
Evaluation of the role of SsaV ‘Salmonella pathogenicity island-2 dependent type III secretion system components on the virulence behavior of Salmonella enterica serovar Typhimurium (2017).
89 -
The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways (2017).
90 -
Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer (2016).
91 -
Antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from urinary tract infections in Zagazig University hospitals (2016).
92 -
TALENs Construction: Slowly but Surely (2016).
93 -
Benzotriazole-Mediated Synthesis and Antibacterial Activity of Novel N-Acylcephalexins (2016).
94 -
Hepatitis C virus pathogenesis: Serum IL-33 level indicates liver damage (2015).
95 -
Development of an Effective Cancer Vaccine Using Attenuated Salmonella and Type III Secretion System to Deliver Recombinant Tumor-Associated Antigens (2014).
96 -
Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system (2014).
97 -
Potent therapeutic activity of a novel Salmonella-based cancer vaccine (2013).
98 -
Salmonella enterica as a vaccine carrier (2012).
99 -
Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens (2012).
100 -
Studies on Pseudomonas Cepacia Isolated from Cystic Fibrosis Patients and Narural Sourses. (1900).
تسجيل الدخول
دخول
2026 all rights reserved.
Zagazig University
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
شراقوة | الشرقية بين ايديك
اخبار الشرقية - شراقوة | الشرقية بين ايديك
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف